AbbVie says FDA approves Skyrizi for ulcerative colitis
AbbVie said that the heavily-advertised drug was now approved for four conditions across different so-called “immune-mediated” inflammatory diseases.
AbbVie said that the heavily-advertised drug was now approved for four conditions across different so-called “immune-mediated” inflammatory diseases.
Trump Media & Technology Group Corp. — the company behind former President Donald Trump’s Truth Social platform — said Tuesday that regulators allowed some of...
Amazon has been fined $5.9 million by a California labor agency accusing the online retailer of failing to sufficiently disclose productivity quotas to employees at...
A private-equity firm led by Wall Street veterans that has backed Willie Nelson’s pot brand Willie’s Reserve as well as multi-state operator Verano has been...
The chip maker led by CEO Jensen Huang ended Tuesday as the most valuable listed U.S. company and helped push the S&P index to a...
“It could be something to remember him by, as they were close.”
Citigroup’s investment banking unit is being driven by better mergers and acquisitions activity as well as capital-raising.
The U.S. budget deficit is projected to hit $1.92 trillion this year, up from $1.69 trillion in 2023, according to updated projections from the Congressional...
As the jobless level has ticked up in recent months, the "Sahm Rule" has generated increasing talk on Wall Street.